Profile data is unavailable for this security.
About the company
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in CNY (TTM)260.30bn
- Net income in CNY3.77bn
- Incorporated1994
- Employees48.16k
- LocationShanghai Pharmaceuticals Holding Co LtdShanghai Pharmaceutical MansionNo.200 Taicang RoadSHANGHAI 200020ChinaCHN
- Phone+86 2 163730908
- Fax+86 2 163289333
- Websitehttps://www.sphchina.com/index/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tibet Rhodiola Pharmaceutical Holding Co | 3.13bn | 800.91m | 11.84bn | 601.00 | 14.78 | 3.54 | -- | 3.78 | 3.23 | 3.23 | 12.64 | 13.49 | 0.7216 | 1.83 | 5.71 | 5,215,189.00 | 18.65 | 12.44 | 25.21 | 15.71 | 93.83 | 90.51 | 25.85 | 20.43 | 2.78 | 7.59 | 0.1294 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 1.11bn | -324.42m | 11.85bn | 1.95k | -- | 6.86 | -- | 10.66 | -0.6628 | -0.6628 | 2.27 | 3.53 | 0.4005 | 0.8061 | 1.31 | 569,846.60 | -12.26 | -1.17 | -16.80 | -1.67 | 69.24 | 71.94 | -30.62 | -3.27 | 1.55 | -18.71 | 0.1474 | -- | 16.44 | -3.17 | -26.08 | -- | -50.29 | -- |
| China Meheco Group Co Ltd | 40.47bn | 563.10m | 16.26bn | 8.31k | 28.88 | 1.45 | -- | 0.4018 | 0.3764 | 0.3764 | 27.05 | 7.48 | 1.13 | 5.58 | 2.76 | 4,868,542.00 | 2.05 | 4.09 | 4.44 | 9.37 | 11.07 | 15.92 | 1.81 | 3.38 | 1.16 | 21.23 | 0.3262 | 38.19 | 3.75 | 4.37 | 13.70 | -10.94 | 12.63 | -4.53 |
| China National Medicines Corp Ltd | 49.70bn | 2.15bn | 26.32bn | 3.14k | 12.26 | 1.67 | -- | 0.5296 | 2.84 | 2.84 | 65.87 | 20.91 | 1.60 | 11.93 | 6.76 | 15,836,850.00 | 7.52 | 7.32 | 14.58 | 15.03 | 7.80 | 8.15 | 4.70 | 4.31 | 1.75 | -- | 0.1526 | 30.04 | 9.23 | 5.11 | 9.26 | 8.85 | 1.84 | 16.38 |
| Jointown Pharmaceutical Group Co Ltd | 151.84bn | 2.17bn | 32.05bn | 30.14k | 14.84 | 1.35 | -- | 0.2111 | 0.5524 | 0.5524 | 38.85 | 6.06 | 1.63 | 9.43 | 4.08 | 5,037,721.00 | 2.40 | 3.04 | 8.03 | 9.58 | 7.76 | 8.35 | 1.47 | 2.04 | 0.9936 | 3.71 | 0.573 | 41.91 | 14.72 | 13.69 | -14.91 | 9.14 | 2.66 | 37.97 |
| Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd | 75.52bn | 4.06bn | 48.26bn | 28.05k | 12.57 | 1.46 | -- | 0.639 | 2.49 | 2.49 | 46.45 | 21.48 | 0.9855 | 5.56 | 5.04 | 2,692,363.00 | 5.56 | 5.90 | 11.17 | 12.40 | 18.33 | 18.70 | 5.64 | 5.56 | 1.23 | -- | 0.3013 | 30.02 | 6.68 | 12.32 | 2.25 | 3.34 | 27.75 | 12.05 |
| Shanghai Pharmaceuticals Holding Co Ltd | 260.30bn | 3.77bn | 58.48bn | 48.16k | 17.22 | 0.9512 | -- | 0.2247 | 1.02 | 1.02 | 70.33 | 18.50 | 1.27 | 6.46 | 3.73 | 5,404,350.00 | 2.52 | 3.53 | 6.70 | 9.34 | 11.75 | 13.21 | 1.98 | 2.66 | 1.03 | 7.59 | 0.4351 | 32.89 | 12.21 | 10.35 | -32.92 | -0.5896 | 8.86 | 0.00 |
| Zhangzhou Pientzhng Phrmctcl Co Ltd | 9.68bn | 2.82bn | 138.37bn | 2.72k | 48.99 | 10.64 | -- | 14.30 | 4.68 | 4.68 | 16.04 | 21.56 | 0.6537 | 2.05 | 13.47 | 3,558,128.00 | 19.55 | 19.02 | 23.73 | 24.40 | 45.61 | 45.90 | 29.90 | 27.27 | 5.02 | -- | 0.0714 | 31.71 | 8.38 | 18.54 | 1.66 | 25.10 | 27.59 | 23.79 |
Data as of Apr 18 2024. Currency figures normalised to Shanghai Pharmaceuticals Holding Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
7.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 22.06m | 1.15% |
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 19.57m | 1.02% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 19.52m | 1.01% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 14.93m | 0.78% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2023 | 12.45m | 0.65% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2023 | 11.60m | 0.60% |
| GF Fund Management Co., Ltd.as of 30 Jun 2023 | 10.36m | 0.54% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 8.80m | 0.46% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 8.40m | 0.44% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2023 | 7.15m | 0.37% |
More ▼
Data from 30 Jun 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
